BOSTON--(BUSINESS WIRE)--Highland Instruments, Inc., (“Highland”) today announced the award for a Fast Track SBIR Grant from the National Center for Complementary and Integrative Health (“NCCIH”) for the clinical evaluation of Highland’s ElectroSonic Stimulation (“ESStim™”) technology for noninvasive brain stimulation for pain suppression in patients with Osteoarthritis of the Knee (“OA”)1. The main academic partner collaborator in this grant and location of the clinical trial will be Spaulding Rehabilitation (“Spaulding”) Hospital’s Laboratory of Neuromodulation (Boston). Felipe Fregni, MD, PhD, MPH, will be the Lead Clinical Investigator. Dr. Fregni is the Director of the Laboratory of Neuromodulation at Spaulding Rehabilitation Hospital and Associate Professor of PM&R and Neurology at Harvard Medical School.
Help employers find you! Check out all the jobs and post your resume.
